April 30, 2020 – Free Online Conference
Get inspired by first-hand information from experts across the Healthcare, Clinical Trials, Genomics, and Pharmacovigilance Industries and see how they’re tackling COVID-19.
Future of Health Virtual is an unprecedented series of Virtual Summits inspired by our annual Future of Health Summit, traditionally held in Bratislava in the month of April. In light of the current situation and with the goal of helping businesses and the general public cope with the impact of COVID-19, Why Summits has made the decision to host monthly virtual conferences. Thanks to a meaningful network of global speakers, Future of Health Virtual Summit offers insight into leading business strategies & intelligence and delivers guidance in a time of uncertainty.
9:30-11:00 CET • April 30, 2020
Fast-paced dynamic interviews on strategies & digital tools
We will be looking at how different Healthcare stakeholders across different regions are fighting back COVID 19 pandemics with DIGITAL TOOLS. What the current pandemics mean for the Healthcare Transformation and what cooperation for innovation we see is taking place.
9:30 AM CET
EMMANUEL FOMBU, A MEDICAL FUTURIST and best seller author of The Future of Healthcare: Humans and Machines Partnering for Better Outcomes, will present his vision of how COVID 19 will transform the industry and he will critically react to measures taken by different countries and organizations.
9:37 AM CET
ALI CIGER FROM PFIZER will present how Big Pharma like Pfizer is cooperating with other Healthcare stakeholders to fight the crisis.
9:45 AM CET
BENY RUBINSTEIN, FORMER MICROSOFT EXECUTIVE, currently Start-up advisor will present how Start-up nation, Israel is fighting the crisis and deploying latest technology research and entrepreneurship spirit backed by Israeli authorities’ leadership
9:53 AM CET
YARA ABO EL WAFA, ARAB REGION HEALTHCARE TRANSFORMATION PIONEER, will present her work on scaling up innovations from the MENA region to transform the Healthcare
10:00 AM CET
SHAFIQUE UR REHMAN – CEO OF PRIVATE HOSPITAL will show how his hospital is able to utilize the latest technology to fight the COVID 19
10:08 AM CET
PRIIT TOHVER, ADVISOR FOR DIGITAL SERVICE INNOVATION AT THE ESTONIAN MINISTRY OF SOCIAL AFFAIRS will show how the most advanced digital society -Estonia is using digital tools to fight COVID 19
10:15 AM CET
Q&A session
Tune in to hear three interviews of speakers to see how mobile applications & technological advancements are advancing and being utilized in our mutual effort to fight against the COVID-19 Pandemic.
10:30 AM CET
LIZ ASHALL – PAYNE – CEO OF ORCHA, World’s leading health app evaluation, and advisor organization gives an overview of the best apps that help to fight pandemics and its consequences.
10:37 AM CET
ANDREJ STUNDECAN – CEO OF STEMI, a mobile application used in Slovakia by Emergency Teams and Hospital Medical Personnel to protect hospital staff from COVID 19 infection will talk about his experience to successfully implement Health App from the perspective of App Developer
10:44 AM CET
RAHEL BAILIE – DIRECTOR OF CONTENT AT BABYLON HEALTH, U.K.‘s leading digital healthcare service will talk about the importance of content modeling, including do’s and don’ts.
10:52 AM CET
Q&A session
11:00-12:30 CET • April 30, 2020
Interactive Panel Discussion & Industry Expert Interview
As the world is trying to contain the current pandemic, healthcare leaders start to ask what can we do to provide medicines and vaccines to the market faster. The hard situation and protective measures pose a risk to the new and ongoing Trials that are active worldwide. There is tension between the maximum recommended and minimum essential requirements to conduct a good trial. And to ensure the good quality of the outcome, many try to adjust the way the current Trials are conducted. Decentralized Trials have been here for years, but now more than ever, we need to start using these digital tools to keep providing the best possible care to everyone. With around 56 000 clinical trials worldwide, we need to act fast enough to ensure successful results and progress, and with that, digitals tools whether used for decentralized or hybrid trials can help significantly.
Moderator:
Michaela Vancova, Clinical Operations DIrector, Slovak Research Center
Panelists:
Gareth Powell, Engagement Project Lead and Business Development Officer, NIHR Clinical Research Network
Nurcan Coskun, Global Risk-Based Monitoring Program and Technology Solutions Manager to Clinical Trials, Ex-Medtronic
Matus Hajduk, Clinical Operations Lead, Healthmode
There is no available vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and no drug with proven clinical efficacy, although there are several candidates that might be effective in prevention or treatment. We are seeing many trials and potential medicines being rolled out every day. But these trials need to be large and well designed to provide reliable outcomes.
Open science and data sharing principles need to be applied at all stages of COVID-19 research along with The FAIR guiding principles (Findability, Accessibility, Interoperability, and Reusability) for equitable use and reuse of data.
Several countries are already recommending chemoprevention or treatments for which there is no convincing evidence of benefit and banning the export of these medicines, thereby compromising the trials needed to establish the evidence.
Interviewer
Rastislav Malejcik, Medical Science Liaison, Kyowa Kirin International plc
Interviewee
Jan Bosak, Clinical Development Manager, Zentiva
13:15 – 14:30 CET • April 30, 2020
Two expert keynotes and an interactive panel discussion
Keynote speech will be focused on not loudly voiced environmental factors halting or mitigating viral infection and disease, based on glycomics research.
This exciting lecture will also provide listeners with a simple, yet essential tip on how to decrease the chances of infection and severe manifestations of the disease!
Gordan Lauc, Co-director of Human Glycome Project
This presentation will provide insight into current bioinformatic pipelines for Next Generation Sequencing Data output, discuss possibilities of crowdsourcing COVID-19 data, as well as provide brief but scrupulous insight into basic biology of the virus, which is often misinterpreted mainly due to current overabundance of information about COVID-19, often from unverified sources
Michael Edwards, Bioinfo Solutions LCC
There are well studied polymorphisms in our genome associated with resistance to viral infection, e.g. HIV (CCR5-delta 32). What are our possibilities and methods to identify variants associated with susceptibility to COVID-19 infection?
Andrea Riposati, CEO Dante Labs
14:30 – 15:30 CET • April 30, 2020
Two back-to-back insightful panel discussions on continuity & digital tools.
This panel discussion will be focused on how PV teams are working effectively and safely during the current pandemic. What leaders are doing to help their teams, what procedures are in place to ensure everyone remains healthy, and how working remotely can be managed effectively. How are leaders also helping teams in a time of uncertainty and their mental health?
Moderator:
Mark Perrot–Head of Development Consulting Huron Life Sciences, UK
Panelists:
James Whitehead- Patient Safety Medical Device Lead, AstraZeneca, UK
Deepa Arora- Director, CLINEXEL Life Sciences Private Limited, India
Marie-Claire Wilson- Director/Senior Consultant Huron Life Sciences, UK
Alexandr Meszaros– PV Consultant Switzerland
This panel discussion will be focused on how digital tools are accelerated and very needed during the current pandemic. What tools teams are using and how this might create more innovation and digitalization within drug safety operations.
Moderator:
Mark Perrot–Head of Development Consulting Huron Life Sciences, UK
Panelists:
Marie-Claire Wilson- Director/Senior Consultant Huron Life Sciences, UK
Alexandr Meszaros– PV Consultant Switzerland
